Nine Square Therapeutics

Nine Square Therapeutics

Biotechnology

South San Francisco, CA 1,094 followers

A quest to alter the trajectory of neurodegenerative disease

About us

Founded by life sciences venture capital firm ATP and renowned scientists at the University of California San Francisco (UCSF), Nine Square is uniting machine learning-enabled image-based cell profiling, chemistry and computational sciences to develop more effective drugs, faster. We are building a diversified portfolio of first-in class drug candidates for genetically validated targets on the autophagy/lysosomal pathway to overcoming the historical challenges of treating severe neurodegenerative diseases. We are currently advancing multiple programs through preclinical development, with lead optimization efforts underway towards IND-enabling studies.

Industry
Biotechnology
Company size
11-50 employees
Headquarters
South San Francisco, CA
Type
Privately Held
Founded
2020

Locations

  • Primary

    285 East Grand Avenue

    Suite 2200

    South San Francisco, CA 94080, US

    Get directions

Employees at Nine Square Therapeutics

Updates

Similar pages

Browse jobs

Funding

Nine Square Therapeutics 2 total rounds

Last Round

Grant

US$ 4.5M

See more info on crunchbase